Cargando...
Harnessing the polyamine transport system to treat BRAF inhibitor-resistant melanoma
BRAF mutations are present in over half of all melanoma tumors. Although BRAF inhibitors significantly improve survival of patients with metastatic melanoma, recurrences occur within several months. We previously reported that BRAF mutant melanoma cells are more sensitive to a novel arylmethyl-polya...
Guardado en:
| Publicado en: | Cancer Biol Ther |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8043175/ https://ncbi.nlm.nih.gov/pubmed/33602034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2021.1883185 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|